(HealthDay)—In two real-world studies, Pfizer’s COVID-19 vaccine appears to be standing up well against the challenges posed by more contagious coronavirus variants from Britain and South Africa.
(HealthDay)—In two real-world studies, Pfizer’s COVID-19 vaccine appears to be standing up well against the challenges posed by more contagious coronavirus variants from Britain and South Africa.
